STERIS (STE) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

STE Stock Forecast

STERIS stock forecast is as follows: an average price target of $256.67 (represents a 18.96% upside from STE’s last price of $215.77) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.

STE Price Target

The average price target for STERIS (STE) is $256.67 based on 1-year price targets from 4 Wall Street analysts in the past 3 months, with a price target range of $265.00 to $245.00. This represents a potential 18.96% upside from STE's last price of $215.77.

STE Analyst Ratings

Buy

According to 4 Wall Street analysts, STERIS's rating consensus is 'Buy'. The analyst rating breakdown for STE stock is 0 'Strong Buy' (0.00%), 3 'Buy' (75.00%), 1 'Hold' (25.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

STERIS Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Oct 24, 2024	Jason Bednar	Piper Sandler	$260.00	$221.15	17.57%	20.50%
Sep 03, 2024	Brett Fishbin	KeyBanc	$265.00	$241.10	9.91%	22.82%
May 10, 2024	Jason Bednar	Piper Sandler	$225.00	$225.94	-0.42%	4.28%
Apr 04, 2024	Mike Polark	Wolfe Research	$245.00	$216.65	13.09%	13.55%

Row per page

Go to

The latest STERIS stock forecast, released on Oct 24, 2024 by Jason Bednar from Piper Sandler, set a price target of $260.00, which represents a 17.57% increase from the stock price at the time of the forecast ($221.15), and a 20.50% increase from STE last price ($215.77).

STERIS Price Target by Period

	1M	3M	12M
# Anlaysts	1	2	4
Avg Price Target	$260.00	$262.50	$248.75
Last Closing Price	$215.77	$215.77	$215.77
Upside/Downside	20.50%	21.66%	15.28%

In the current month, the average price target of STERIS stock is $260.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 20.50% increase as opposed to STERIS's last price of $215.77. This month's average price target is down -0.95% compared to last quarter, and up 4.52% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Oct 24, 2024	Stephens	Market Outperform	Market Outperform	Hold
Oct 24, 2024	Piper Sandler	Underperform	Underperform	Hold
Oct 24, 2024	Piper Sandler	Neutral	Overweight	Upgrade
Sep 03, 2024	Stephens	Market Outperform	Market Outperform	Hold
Sep 03, 2024	JMP Securities	Underperform	Underperform	Hold
Sep 03, 2024	KeyBanc	Overweight	Overweight	Hold
Aug 07, 2024	Stephens	Market Outperform	Market Outperform	Hold
Jun 10, 2024	Piper Sandler	Neutral	Neutral	Hold
May 10, 2024	Piper Sandler	Neutral	Neutral	Hold
Apr 04, 2024	Wolfe Research	Outperform	Outperform	Hold

Row per page

Go to

STERIS's last stock rating was published by Stephens on Oct 24, 2024. The company gave STE a "Market Outperform" rating, the same as its previous rate.

STERIS Financial Forecast

STERIS Revenue Forecast

	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	$1.40B	$1.34B	$1.28B	$1.38B	$1.22B	$1.20B	$1.16B	$1.21B	$968.42M	$1.20B	$1.21B	$873.53M	$668.93M	$756.13M	$808.92M	$822.99M	$696.80M
Avg Forecast	$1.69B	$1.56B	$1.51B	$1.44B	$1.58B	$1.47B	$1.41B	$1.36B	$1.50B	$1.38B	$1.33B	$1.27B	$1.41B	$1.35B	$1.30B	$1.21B	$1.27B	$1.27B	$1.22B	$1.22B	$1.17B	$1.19B	$1.15B	$904.86M	$876.22M	$793.03M	$719.54M	$643.38M	$799.57M	$748.45M
High Forecast	$1.70B	$1.58B	$1.52B	$1.45B	$1.60B	$1.48B	$1.43B	$1.38B	$1.52B	$1.39B	$1.33B	$1.27B	$1.41B	$1.36B	$1.31B	$1.22B	$1.29B	$1.29B	$1.22B	$1.22B	$1.17B	$1.19B	$1.15B	$904.86M	$876.22M	$793.03M	$719.54M	$643.38M	$799.57M	$748.45M
Low Forecast	$1.67B	$1.55B	$1.49B	$1.43B	$1.57B	$1.46B	$1.40B	$1.35B	$1.49B	$1.37B	$1.33B	$1.27B	$1.41B	$1.34B	$1.28B	$1.20B	$1.26B	$1.26B	$1.22B	$1.22B	$1.17B	$1.19B	$1.15B	$904.86M	$876.22M	$793.03M	$719.54M	$643.38M	$799.57M	$748.45M
# Analysts	4	4	4	4	4	3	3	3	5	5	4	1	1	3	5	4	4	3	3	3	3	4	4	4	4	4	15	9	9	8
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	1.03%	1.03%	1.06%	1.09%	0.96%	0.98%	0.95%	1.03%	0.81%	1.04%	1.34%	1.00%	0.84%	1.05%	1.26%	1.03%	0.93%

STERIS's average Quarter revenue forecast for Mar 24 based on 1 analysts is $1.41B, with a low forecast of $1.41B, and a high forecast of $1.41B. STE's average Quarter revenue forecast represents a 1.13% increase compared to the company's last Quarter revenue of $1.40B (Dec 23).

STERIS EBITDA Forecast

	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19
# Analysts	4	4	4	4	4	3	3	3	5	5	4	1	1	3	5	4	4	3	3	3	3	4	4	4	4	4	15	9	9	8
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	$216.16M	$185.86M	$188.92M	$226.12M	$190.88M	$318.09M	$158.45M	$91.92M	$76.47M	$230.90M	$322.78M	$203.66M	$165.41M	$196.79M	$205.17M	$208.54M	$158.58M
Avg Forecast	$424.04M	$392.39M	$379.00M	$362.05M	$397.78M	$369.37M	$355.38M	$342.81M	$377.01M	$347.58M	$334.60M	$320.02M	$344.19M	$339.16M	$326.75M	$303.66M	$312.90M	$527.34M	$240.36M	$240.60M	$284.45M	$234.89M	$226.54M	$177.97M	$224.86M	$155.98M	$141.52M	$126.54M	$200.70M	$147.21M
High Forecast	$428.48M	$396.50M	$382.97M	$365.84M	$401.95M	$373.23M	$359.10M	$346.39M	$382.07M	$350.10M	$334.62M	$320.02M	$413.03M	$341.69M	$330.36M	$306.84M	$375.48M	$632.80M	$240.36M	$240.60M	$341.34M	$234.89M	$226.54M	$177.97M	$269.84M	$155.98M	$141.52M	$126.54M	$240.85M	$147.21M
Low Forecast	$420.28M	$388.91M	$375.64M	$358.84M	$394.26M	$366.09M	$352.23M	$339.77M	$374.48M	$345.06M	$334.57M	$320.02M	$275.35M	$336.63M	$322.57M	$300.97M	$250.32M	$421.87M	$240.36M	$240.60M	$227.56M	$234.89M	$226.54M	$177.97M	$179.89M	$155.98M	$141.52M	$126.54M	$160.56M	$147.21M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.64%	0.57%	0.62%	0.72%	0.36%	1.32%	0.66%	0.32%	0.33%	1.02%	1.81%	0.91%	1.06%	1.39%	1.62%	1.04%	1.08%

1 analysts predict STE's average Quarter EBITDA for Mar 24 to be $344.19M, with a high of $413.03M and a low of $275.35M. This is 59.23% upper than STERIS's previous annual EBITDA (Dec 23) of $216.16M.

STERIS Net Income Forecast

	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19
# Analysts	4	4	4	4	4	3	3	3	5	5	4	1	1	3	5	4	4	3	3	3	3	4	4	4	4	4	15	9	9	8
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	$140.74M	$115.32M	$123.55M	$187.22M	$123.83M	$-315.23M	$111.26M	$52.26M	$-21.90M	$69.81M	$-21.81M	$88.85M	$88.12M	$105.86M	$88.19M	$123.32M	$104.93M
Avg Forecast	$311.79M	$277.96M	$262.73M	$244.01M	$283.89M	$252.47M	$235.61M	$226.52M	$260.48M	$230.44M	$210.60M	$196.14M	$147.46M	$215.13M	$198.74M	$184.52M	$134.05M	$144.21M	$197.10M	$190.31M	$121.87M	$194.98M	$180.86M	$148.27M	$96.34M	$150.89M	$125.88M	$97.19M	$118.63M	$141.11M
High Forecast	$316.03M	$281.75M	$266.30M	$247.33M	$287.75M	$255.91M	$238.81M	$229.60M	$265.57M	$238.52M	$211.15M	$196.15M	$176.95M	$217.12M	$204.67M	$187.03M	$160.87M	$173.05M	$197.10M	$190.31M	$146.24M	$198.48M	$180.86M	$148.27M	$115.61M	$150.89M	$125.88M	$97.19M	$142.36M	$141.11M
Low Forecast	$308.19M	$274.76M	$259.70M	$241.19M	$280.62M	$249.56M	$232.89M	$223.90M	$250.31M	$222.35M	$210.04M	$196.13M	$117.97M	$214.13M	$187.86M	$182.39M	$107.24M	$115.37M	$197.10M	$190.31M	$97.49M	$191.47M	$180.86M	$148.27M	$77.07M	$150.89M	$125.88M	$97.19M	$94.91M	$141.11M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.65%	0.58%	0.67%	1.40%	0.86%	-1.60%	0.58%	0.43%	-0.11%	0.39%	-0.15%	0.92%	0.58%	0.84%	0.91%	1.04%	0.74%

STERIS's average Quarter net income forecast for Mar 24 is $147.46M, with a range of $117.97M to $176.95M. STE's average Quarter net income forecast represents a 4.77% increase compared to the company's last Quarter net income of $140.74M (Dec 23).

STERIS SG&A Forecast

	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19
# Analysts	4	4	4	4	4	3	3	3	5	5	4	1	1	3	5	4	4	3	3	3	3	4	4	4	4	4	15	9	9	8
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	-	$360.52M	$380.65M	$359.06M	$335.91M	$305.14M	$323.19M	$334.63M	$453.64M	$393.75M	$344.80M	$310.56M	$221.07M	$155.17M	$172.71M	$182.37M	$189.06M	$178.78M
Avg Forecast	$440.16M	$407.30M	$393.41M	$375.81M	$412.91M	$383.41M	$368.89M	$355.84M	$391.34M	$360.79M	$347.31M	$332.18M	$366.90M	$352.05M	$339.17M	$315.21M	$333.54M	$311.84M	$317.71M	$318.04M	$303.22M	$310.48M	$299.44M	$235.25M	$239.70M	$206.18M	$187.07M	$167.27M	$181.88M	$194.58M
High Forecast	$444.77M	$411.57M	$397.52M	$379.74M	$417.23M	$387.42M	$372.75M	$359.56M	$396.59M	$363.40M	$347.34M	$332.18M	$440.28M	$354.68M	$342.92M	$318.50M	$400.25M	$374.21M	$317.71M	$318.04M	$363.86M	$310.48M	$299.44M	$235.25M	$287.64M	$206.18M	$187.07M	$167.27M	$218.26M	$194.58M
Low Forecast	$436.26M	$403.69M	$389.92M	$372.48M	$409.24M	$380.01M	$365.62M	$352.68M	$388.71M	$358.18M	$347.29M	$332.18M	$293.52M	$349.42M	$334.83M	$312.41M	$266.83M	$249.47M	$317.71M	$318.04M	$242.58M	$310.48M	$299.44M	$235.25M	$191.76M	$206.18M	$187.07M	$167.27M	$145.51M	$194.58M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	1.02%	1.12%	1.14%	1.01%	0.98%	1.02%	1.05%	1.50%	1.27%	1.15%	1.32%	0.92%	0.75%	0.92%	1.09%	1.04%	0.92%

STERIS's average Quarter SG&A projection for Mar 24 is $366.90M, based on 1 Wall Street analysts, with a range of $293.52M to $440.28M. The forecast indicates a 1.77% rise compared to STE last annual SG&A of $360.52M (Dec 23).

STERIS EPS Forecast

	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19
# Analysts	4	4	4	4	4	3	3	3	5	5	4	1	1	3	5	4	4	3	3	3	3	4	4	4	4	4	15	9	9	8
EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	$1.42	$1.17	$1.25	$1.89	$1.24	$-3.15	$1.11	$0.52	$-0.24	$0.70	$1.43	$1.02	$1.04	$1.24	$1.34	$1.45	$1.00
Avg Forecast	$3.14	$2.80	$2.65	$2.46	$2.86	$2.54	$2.38	$2.28	$2.63	$2.32	$2.12	$1.98	$2.35	$2.17	$2.00	$1.86	$2.15	$2.19	$1.98	$1.92	$2.02	$1.96	$1.82	$1.49	$1.77	$1.52	$1.27	$0.98	$1.57	$1.42
High Forecast	$3.19	$2.84	$2.68	$2.49	$2.90	$2.58	$2.41	$2.31	$2.68	$2.40	$2.13	$1.98	$2.38	$2.19	$2.06	$1.89	$2.18	$2.22	$1.98	$1.92	$2.02	$2.00	$1.82	$1.49	$1.77	$1.52	$1.27	$0.98	$1.57	$1.42
Low Forecast	$3.11	$2.77	$2.62	$2.43	$2.83	$2.52	$2.35	$2.26	$2.52	$2.24	$2.12	$1.98	$2.32	$2.16	$1.89	$1.84	$2.12	$2.17	$1.98	$1.92	$2.02	$1.93	$1.82	$1.49	$1.77	$1.52	$1.27	$0.98	$1.57	$1.42
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.65%	0.58%	0.67%	0.88%	0.57%	-1.59%	0.58%	0.26%	-0.12%	0.38%	0.96%	0.57%	0.68%	0.98%	1.37%	0.92%	0.70%

According to 1 Wall Street analysts, STERIS's projected average Quarter EPS for Mar 24 is $2.35, with a low estimate of $2.32 and a high estimate of $2.38. This represents a 65.49% increase compared to STE previous annual EPS of $1.42 (Dec 23).

STERIS Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
IRTC	iRhythm	$73.90	$121.17	63.96%	Buy
LIVN	LivaNova	$51.70	$70.50	36.36%	Buy
CNMD	CONMED	$71.71	$96.00	33.87%	Buy
BRKR	Bruker	$56.22	$73.75	31.18%	Buy
OFIX	Orthofix Medical	$18.68	$24.00	28.48%	-
STE	STERIS	$215.77	$256.67	18.96%	Buy
SNN	Smith & Nephew	$25.04	$27.00	7.83%	Buy
ZIMV	ZimVie	$13.74	$14.50	5.53%	Buy
PODD	Insulet	$262.00	$274.00	4.58%	Buy
ITGR	Integer	$135.88	$138.00	1.56%	Buy
MASI	Masimo	$169.12	$161.83	-4.31%	Buy
PEN	Penumbra	$240.49	$224.85	-6.50%	Buy
GKOS	Glaukos	$140.83	$123.44	-12.35%	Buy
SYK	Stryker	$390.14	$317.96	-18.50%	Buy

STE Forecast FAQ

Is STERIS a good buy?

Yes, according to 4 Wall Street analysts, STERIS (STE) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 3 'Buy' recommendations, accounting for 75.00% of STE's total ratings.

What is STE's price target?

STERIS (STE) average price target is $256.67 with a range of $245 to $265, implying a 18.96% from its last price of $215.77. The data is based on 4 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will STERIS stock go up soon?

According to Wall Street analysts' prediction for STE stock, the company can go up by 18.96% (from the last price of $215.77 to the average price target of $256.67), up by 22.82% based on the highest stock price target, and up by 13.55% based on the lowest stock price target.

Can STERIS stock reach $300?

STE's average twelve months analyst stock price target of $256.67 does not support the claim that STERIS can reach $300 in the near future.

What is STERIS's current price target trend?

1 Wall Street analyst forecast a $260 price target for STERIS (STE) this month, up 20.50% from its last price of $215.77. Compared to the last 3 and 12 months, the average price target increased by 21.66% and increased by 15.28%, respectively.

What are STERIS's analysts' financial forecasts?

STERIS's analysts financial forecasts for the fiscal year (Mar 2026) are as follows: average revenue is $5.83B (high $5.89B, low $5.77B), average EBITDA is $1.47B (high $1.48B, low $1.45B), average net income is $998.49M (high $1.01B, low $986.98M), average SG&A $1.52B (high $1.54B, low $1.51B), and average EPS is $10.06 (high $10.2, low $9.95). STE's analysts financial forecasts for the fiscal year (Mar 2027) are as follows: average revenue is $6.19B (high $6.26B, low $6.14B), average EBITDA is $1.56B (high $1.57B, low $1.54B), average net income is $1.1B (high $1.11B, low $1.08B), average SG&A $1.62B (high $1.63B, low $1.6B), and average EPS is $11.05 (high $11.2, low $10.93).

Did the STE's actual financial results beat the analysts' financial forecasts?

Based on STERIS's last annual report (Mar 2023), the company's revenue was $4.96B, which missed the average analysts forecast of $4.99B by -0.66%. Apple's EBITDA was $1.25B, missing the average prediction of $1.32B by -5.37%. The company's net income was $107.03M, missing the average estimation of $665.67M by -83.92%. Apple's SG&A was $1.3B, beating the average forecast of $1.28B by 1.39%. Lastly, the company's EPS was $1.07, missing the average prediction of $8.24 by -87.01%. In terms of the last quarterly report (Dec 2023), STERIS's revenue was $1.4B, beating the average analysts' forecast of $1.35B by 3.49%. The company's EBITDA was $216.16M, missing the average prediction of $339.16M by -36.27%. STERIS's net income was $140.74M, missing the average estimation of $215.13M by -34.58%. The company's SG&A was $360.52M, beating the average forecast of $352.05M by 2.41%. Lastly, the company's EPS was $1.42, missing the average prediction of $2.17 by -34.52%